S

Sobi

Develops therapies for rare diseases

Senior Medical Science Liaison - Lymphoma, Lacutamab

Biology & BiotechConfirmed live in the last 24 hours
Full-timePhoenix, AZ, USA

About the Job

Requirements

  • An accredited doctorate degree in a life-science, health-science, or basic-science discipline, such as PharmD, PhD, DNP, DSc, MD, or DO, is required. Candidates with another advanced health degree and extensive relevant industry or clinical experience may be considered.
  • At least 5 years of Medical Science Liaison experience in hematology/oncology, heme-onc, or a closely related therapeutic area is required.
  • Strong ability to understand, critically evaluate, and clearly communicate complex scientific and clinical information.
  • Strong commitment to patient needs and advancing scientific understanding within the cutaneous T-cell lymphoma community.
  • Ability to attend local, regional, and national meetings, including occasional evening or weekend programs, as business needs require.
  • Ability to work effectively from a remote office and manage a geographically dispersed territory.

Responsibilities

  • Serve as a primary field-based scientific point of contact for Sobi Medical Affairs within the assigned geography.
  • Develop and maintain meaningful, two-way relationships with opinion leaders, healthcare professionals, medical organizations, investigators, and other stakeholders involved in cutaneous T-cell lymphoma care.
  • Exchange accurate, fair, balanced, and scientifically rigorous information on cutaneous T-cell lymphoma, lacutamab, relevant clinical data, disease biology, treatment approaches, and the evolving care landscape.
  • Engage across academic, community, and multidisciplinary settings, including hematology-oncology, dermatology, and dermato-oncology practices.
  • Respond appropriately to unsolicited scientific inquiries and connect stakeholders with Sobi resources in line with applicable policies and procedures.
  • Identify, document, and share high-quality field insights on unmet needs, clinical practice, patient pathways, evidence gaps, stakeholder perspectives, competitive developments, and the treatment landscape.
  • Partner with Medical Affairs leadership and cross-functional colleagues to interpret insights and inform adjustments to medical strategy, tactics, educational priorities, and engagement plans.
  • Execute territory-level medical plans aligned with the US cutaneous T-cell lymphoma and lacutamab medical strategy, adapting engagement to local and regional stakeholder needs.
  • Support key institution and stakeholder engagement planning, helping establish Sobi as a trusted scientific partner in cutaneous T-cell lymphoma.
  • Contribute to lacutamab launch preparedness through disease-state education, articulation of unmet need, scientific exchange, stakeholder mapping, and field execution of approved medical tactics.
  • Provide internal and external scientific training on cutaneous T-cell lymphoma disease biology, preclinical science, clinical data, evidence gaps, and relevant outcomes.
  • Participate in or support advisory boards, medical roundtables, webinars, symposia, and other educational activities at local, regional, and national levels.
  • Represent Sobi Medical Affairs at scientific and medical congresses, and synthesize and communicate key updates and implications to internal stakeholders.
  • Collaborate to identify and develop field resources and scientific materials specific to cutaneous T-cell lymphoma and lacutamab.
  • Provide field-based support to Clinical Development and Clinical Operations, including site identification and recommendations, investigator engagement, communication facilitation, site initiation support, and patient accrual support.
  • Identify evidence gaps and potential research opportunities, and communicate them to appropriate internal partners.
  • Contribute scientific and field perspectives to evidence generation activities, real-world evidence initiatives, publications, and medical education programs, as appropriate.
  • Support investigator-sponsored research and other research collaborations in accordance with company processes and governance.
  • Partner with colleagues in Medical Affairs, Medical Information, Clinical Development, Market Access, Patient Advocacy, Commercial, Legal, Compliance, and other functions, while maintaining the independence and integrity of the Medical Affairs role.
  • Serve as a scientific resource to internal stakeholders and contribute to cross-functional initiatives consistent with Medical Affairs objectives and company guidelines.
  • Demonstrate excellence in territory planning, stakeholder prioritization, documentation, follow-through, and management of multiple projects and competing priorities.
  • Contribute to the broader Field Medical organization's success by sharing best practices, supporting colleagues, and fostering a collaborative, respectful, patient-focused culture.
  • Travel domestically by ground and/or air frequently, at least 60% or more depending on territory size, stakeholder needs, congress participation, and business requirements.

Desired Qualifications

  • Further experience in clinical practice, cutaneous T-cell lymphoma, peripheral T-cell lymphoma, lymphoma, dermatology, or dermato-oncology is highly valued.
  • Experience in rare disease and/or product launch is highly valued.
  • Clinical hematology-oncology background is highly preferred.
  • Knowledge of cutaneous T-cell lymphoma and/or peripheral T-cell lymphoma and the multidisciplinary care environment is an advantage.

About the Company

Sobi

Develops therapies for rare diseases

Sobi specializes in developing and delivering therapies for rare diseases. It focuses on hematology, immunology, and specialty care, bringing medicines to patients who have limited treatment options. Their products are designed to treat rare conditions and are typically administered by prescription under medical supervision; the company collaborates with partners to advance research, develop, and commercialize these therapies. Sobi differentiates itself through its strong biotechnological foundation from its Biovitrum heritage and a track record of strategic collaborations with major pharmaceutical players like Sanofi and Apellis, which expand its research capabilities and reach. The company’s goal is to improve the lives of patients with rare diseases worldwide by creating and delivering effective treatments that address unmet medical needs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Solna kommun, Sweden
Founded
1988

Recently Posted Jobs

Explore more opportunities at Sobi

See more jobs